Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Vaccines Efficacy and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT01651663
What this trial is testing

Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold

Who this might be right for
Influenza
Pharmstandard 840
Early research (Phase 1)Study completedNCT00662272
What this trial is testing

Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant

Who this might be right for
Influenza
Colby Pharmaceutical Company 128
Testing effectiveness (Phase 2)Study completedNCT03220048
What this trial is testing

Study Examining PrEP-001 in Healthy Subjects

Who this might be right for
Influenza A H3N2
Hvivo 66
Testing effectiveness (Phase 2)Study completedNCT00453999
What this trial is testing

Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza

Who this might be right for
Influenza
BioCryst Pharmaceuticals 137
Post-approval studies (Phase 4)Study completedNCT03154515
What this trial is testing

Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults

Who this might be right for
Common ColdInfluenza, HumanAcute Respiratory Infection
Valenta Pharm JSC 445
Testing effectiveness (Phase 2)Looking for participantsNCT07420985
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.

Who this might be right for
InfluenzaAcute Respiratory Viral Infection
Valenta Pharm JSC 300
Testing effectiveness (Phase 2)WithdrawnNCT03028909
What this trial is testing

Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.

Who this might be right for
Influenza - Type A Strains
MedImmune LLC
Large-scale testing (Phase 3)Looking for participantsNCT06528444
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza

Who this might be right for
Influenza
Instituto de Investigación Sanitaria y Biomédica de Alicante 42
Large-scale testing (Phase 3)Study completedNCT00979602
What this trial is testing

Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older

Who this might be right for
Influenza
GlaxoSmithKline 4,048
Large-scale testing (Phase 3)Study completedNCT03704740
What this trial is testing

Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months

Who this might be right for
Influenza
SK Bioscience Co., Ltd. 676
Large-scale testing (Phase 3)Study completedNCT02917304
What this trial is testing

Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older

Who this might be right for
Influenza, Human
Green Cross Corporation 274
Testing effectiveness (Phase 2)Study completedNCT04441047
What this trial is testing

Universal Anti-Viral Vaccine for Healthy Elderly Adults

Who this might be right for
Virus DiseasesPneumoniaCOVID-19 Respiratory Infection+3 more
Mirror Biologics, Inc. 40
Large-scale testing (Phase 3)Study completedNCT03460743
What this trial is testing

Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.

Who this might be right for
Influenza, Human
Laboratorios Liomont 1,556
Large-scale testing (Phase 3)Study completedNCT06602024
What this trial is testing

MRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

Who this might be right for
Seasonal Influenza
ModernaTX, Inc. 40,805
Large-scale testing (Phase 3)Study completedNCT00192413
What this trial is testing

Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza

Who this might be right for
Influenza
MedImmune LLC 3,009
Large-scale testing (Phase 3)Study completedNCT00539981
What this trial is testing

Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

Who this might be right for
Influenza
Sanofi 4,648
Testing effectiveness (Phase 2)Study completedNCT04706468
What this trial is testing

To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus Infection

Who this might be right for
Influenza Virus Infection
TaiGen Biotechnology Co., Ltd. 202
Testing effectiveness (Phase 2)Study completedNCT03657719
What this trial is testing

Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects

Who this might be right for
Influenza, Human
Green Cross Corporation 105
Large-scale testing (Phase 3)Not Yet RecruitingNCT07791251
What this trial is testing

Efficacy and Safety of Inhaled Peramivir Solution for the Treatment of Adults With Uncomplicated Influenza

Who this might be right for
Influenza Infection
Capital Medical University 600
Large-scale testing (Phase 3)Study completedNCT01231620
What this trial is testing

Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza

Who this might be right for
Influenza, Human
GlaxoSmithKline 626
Next Page